Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 365 clinical trials
featured
A Phase 1 Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02385 in Participants With Select Advanced Malignancies

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.  This investigational intervention treatment uses a single biological drug and is conducted in two parts. Part 1: INCAGN02385 at the protocol-defined starting dose administered every 2 weeks (Q2W), with dose …

urothelial carcinoma
metastatic cervical cancer
carcinoma
ovarian cancer
  • 156 views
  • 23 Nov, 2020
  • 4 locations
featured
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02390 in Participants With Select Advanced Malignancies

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02390 in participants with advanced malignancies. This investigational intervention treatment uses a single biological drug and is conducted in two parts. Part 1: INCAGN02390 at the protocol-defined starting dose administered every 2 weeks (Q2W), with …

advanced cancer
cancer
  • 128 views
  • 14 Dec, 2020
  • 4 locations
Combination Chemotherapy in Treating Patients With Esophageal Cancer

yet known which regimen of combination chemotherapy is more effective in treating esophageal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of

cancer
combination chemotherapy
esophageal cancer
conventional surgery
tumor cells
  • 31 views
  • 07 Nov, 2020
  • 1 location
Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation

Research has shown that increasing the dose of radiotherapy improves outcomes in patients with lung and head and neck cancers. This study aims to see whether this is also the case for patients with tumour of the oesophagus. This trial will compare the effects of the standard dose of radiotherapy …

cancer
adenocarcinoma
chemoradiotherapy
kidney function test
capecitabine
  • 213 views
  • 08 Nov, 2020
  • 1 location
Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial

Surgery is the standard treatment for esophageal (food pipe) cancer. Esophageal cancer is known to spread to the lymph nodes (glands) adjacent to the esophagus. The extent of lymph nodes

cancer
esophagectomy
adenocarcinoma
lymphadenectomy
esophageal cancer
  • 15 views
  • 07 Nov, 2020
  • 1 location
Proton Therapy for Esophageal Cancer

advanced esophageal cancer and is also a potent radiosensitizer. Second, the substitution of carboplatin for cisplatin has resulted in reduced toxicity of various combination regimens similar to that used

cancer
celiac disease
adenocarcinoma
esophageal cancer
adenocarcinoma of esophagus
  • 77 views
  • 09 Feb, 2020
  • 1 location
SOX-based CRT for Esophageal Cancer.

Patients with esophageal cancer that had locally advanced diseases or with unresectable diseases are being asked to participate in this phase I/II study. This phase I/II study is being

cancer
platelet count
oxaliplatin
neutrophil count
esophageal cancer
  • 3 views
  • 24 Jun, 2019
  • 1 location
Induction Chemotherapy for Locally Advanced Esophageal Cancer

patients with locally advanced esophageal cancer.

cancer
platelet count
adenocarcinoma
chemoradiotherapy
esophageal cancer
  • 8 views
  • 26 Jul, 2020
  • 1 location
Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus

The purpose of this study is to determine the Maximum Tolerated Dose (MTD) of olaparib in combination with radical radiotherapy in patients with oesophageal cancer who are unsuitable for

cancer
platelet count
oesophageal stent
adenocarcinoma
chemoradiotherapy
  • 2 views
  • 08 Nov, 2020
Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Definitive chemoradiotherapy (CRT) is the standard treatment option for unresectable esophageal cancer (EC). However, as high as more than 40% of EC patients experienced locoregional recurrence

  • 2 views
  • 07 Jul, 2019
  • 1 location